Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CVRx (CVRX) Research & Development (2020 - 2025)

CVRx has reported Research & Development over the past 6 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Research & Development at $3.0 million for Q4 2025, up 6.95% from a year ago — trailing twelve months through Dec 2025 was $11.1 million (changed 0.01% YoY), and the annual figure for FY2025 was $11.1 million, changed 0.01%.
  • Research & Development for Q4 2025 was $3.0 million at CVRx, down from $3.1 million in the prior quarter.
  • Over the last five years, Research & Development for CVRX hit a ceiling of $3.4 million in Q1 2023 and a floor of $1.7 million in Q3 2021.
  • Median Research & Development over the past 5 years was $2.5 million (2024), compared with a mean of $2.6 million.
  • Biggest five-year swings in Research & Development: surged 252.35% in 2021 and later fell 26.43% in 2023.
  • CVRx's Research & Development stood at $1.8 million in 2021, then skyrocketed by 69.5% to $3.0 million in 2022, then fell by 26.43% to $2.2 million in 2023, then increased by 25.17% to $2.8 million in 2024, then increased by 6.95% to $3.0 million in 2025.
  • The last three reported values for Research & Development were $3.0 million (Q4 2025), $3.1 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.